Does MIANSERIN Cause Product prescribing issue? 7 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Product prescribing issue have been filed in association with MIANSERIN. This represents 0.3% of all adverse event reports for MIANSERIN.
7
Reports of Product prescribing issue with MIANSERIN
0.3%
of all MIANSERIN reports
7
Deaths
7
Hospitalizations
How Dangerous Is Product prescribing issue From MIANSERIN?
Of the 7 reports, 7 (100.0%) resulted in death, 7 (100.0%) required hospitalization, and 6 (85.7%) were considered life-threatening.
Is Product prescribing issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIANSERIN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does MIANSERIN Cause?
Toxicity to various agents (246)
Fall (201)
Coma (177)
Somnolence (163)
Off label use (141)
Drug abuse (132)
Confusional state (126)
Hyponatraemia (122)
Hypotension (113)
Poisoning deliberate (107)
What Other Drugs Cause Product prescribing issue?
DUPILUMAB (1,715)
POLYETHYLENE GLYCOL 3350 (1,439)
LENALIDOMIDE (948)
OXYCODONE (646)
RIVAROXABAN (359)
ACETAMINOPHEN\OXYCODONE (347)
ETONOGESTREL (311)
ACETAMINOPHEN\HYDROCODONE (298)
CERTOLIZUMAB PEGOL (297)
CABOZANTINIB S-MALATE (294)
Which MIANSERIN Alternatives Have Lower Product prescribing issue Risk?
MIANSERIN vs MICAFUNGIN
MIANSERIN vs MICARDIS
MIANSERIN vs MICONAZOLE
MIANSERIN vs MIDAZOLAM
MIANSERIN vs MIDAZOLAM\MIDAZOLAM